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Objectives: To analyze the relation between the erectile dysfunction and
the 6 minutes walk test (6MWT) in patients with chronic heart failure.
Method and results: The study population consisted of 93 men, aged 42
to 75 years (mean age 62,8years), with CHF and left ventricular dysfunction.
Erectile dysfunction was evaluated with the international index for erectile
function questionnaire-5(IIEF5), ED (IIEF-5, 21-5) was present in 50,5%
(n=47), and no ED (IIEF-5,22-25) in 49,4%(n=46),erectile dysfunction was
found in 37% of patients with 6MWT <200m,compared with 14% of patients
with 6MWT >300m (the difference was statistically significant).
Patient with 6MWT<200m had more severe erectile dysfunction than
patients with 6MWT>300m, 6MWT<200m is correlated with erectile dysfunc-
tion.
Conclusion: The prevalence of erectile dysfunction is higher in patient
with 6MWT<200m compared with patient with 6MWT >300m of similar
demographic characteristics. Erectile dysfunction affects patient quality of life,
underlining the need for vigorous research of this condition and appropriate
management. 
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Purpose: Takotsubo Cardiomyopathy (TCM) is characterized by transient
left ventricular dysfunction in patients with normal findings on coronary angi-
ography. A simultaneous incidence of coronary artery disease and TCM was
described in literature, but the clinical characteristics and the prognosis of this
population have not been yet assessed. The aim of our study is to analyze the
prognostic impact of simultaneous coronary artery disease in patients with
TCM. 
Methods: A retrospective monocentric study enrolling 58 patients hospi-
talized for TCM between January 2002 and January 2013. Demographic char-
acteristics, clinical features, angiographic results and outcomes were analyzed.
Results: The mean age of our population was 58±12 years. Hypertension
and dyslipidemia were the most common risk factors for coronary heart
disease (63.8% and 34.5% respectively). Angiographic assessment demon-
strated atherosclerotic lesions in Left Anterior Descending (LAD) artery in
17þpatients (29.3%), among which 12 patients (20.7%) had only non signifi-
cant lesions. Two patients have significant lesions (stenosis > 50%) in LAD
and three in diagonal artery branch. In-hospital complications occured in
7 patients (12%) and included acute pulmonary oedema (n=5), cardiogenic
shock (n=2) and death (n=2). In univariate analysis, lesions in LAD was a pre-
dictive factor of in-hospital outcomes (p=0.02). However, significant lesions
in LAD were not associated with in-hospital major events (p=0.6). After a
mean follow-up of 56±31 months, long-term major events (death, recurrence
and cardiac hospitalization) occured in 30.4% of patients. Coronary artery dis-
ease was not associated with long-term cardiac events (p=0.58).
Conclusion: Our study demonstrated that coronary lesions in LAD are
associated with in-hospital major cardiac events. 
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The development of diastolic dysfunction (DD) in patients with type 2 dia-
betes mellitus (DM2) is associated not only with hyperglycemia, insulin resis-
tance and dyslipidemia, but also with the activation of pro-inflammatory
cytokines. At the same time the extent of pro-inflammatory cytokines involve-
ment into the development of DD in patients with DM2 remains understudied.
The purpose: of the study was to evaluate the relationship between the
state of resistin activity, level of interleukin-6 (IL-6) and DD in patients with
DM2.
Methods: The study included 102 middle age patients with DM2 without
severe diabetic complications. No clinically significant coronary artery disease
was diagnosed in examined patients; the mean BP level was 133/82mm Hg
(M±m). The levels of resistin and IL-6 were determined by immune-enzyme
assay. Echocardiographic method was performed to measure peak velocity of
early diastolic filling flow (peak E), peak velocity of late diastolic filling flow
(peak A), the peak E/peak A ratio (E/A), and deceleration time of early dia-
stolic filling (DT).
Results: The significant (p<0.05) correlations were revealed between
resistin, IL-6 and DD: between resistin and IL-6 (R=0.71), between resistin
and E/A (R=–0.275), between resistin and DT (R=0.253), between IL-6 and
E/A (R=–0.278).
Conclusions: The received data support the fact that resistin and IL-6,
which are a pro-inflammatory adipokines, along with known risk factors such
as dyslipidemia, insulin resistance, and others, take part in the development of
structural and functional pathology of the myocardium, which subsequently
leads to the formation of chronic heart failure in patients with DM2.
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